-

Gaotu Techedu Inc. (GOTU, GSX) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Gaotu Techedu Inc.

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Gaotu Techedu Inc. (NYSE: GOTU) American depository shares ("ADSs") between March 5, 2021 and July 23, 2021, for violations of the Securities Exchange Act of 1934. Gaotu purports to be a technology-driven education company, providing online K-12 after-school tutoring services in the People's Republic of China.

What Now: Similarly situated shareholders may be eligible to participate in the class action against Gaotu. Shareholders who want to act as lead plaintiff for the class must file their papers by February 28, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: Gaotu Techedu Inc. (GOTU) Failed to Disclose the Impact of China's Ban on For-Profit Tutoring on Its Business Prospects

According to the complaint, during the class period, defendants failed to disclose among other things that: (1) China was barring tutoring for profit in core school subjects and the policy change would restrict foreign investment in a sector that had become essential to success in Chinese school exams; and (2) the impact such regulations would have on Gaotu’s operations and profitability and the value of Company securities.

On July 23, 2021, Reuters reported that China is barring tutoring for profit in core school subjects, which triggered a heavy sell-off in shares of tutoring firms. Further, "[a]ll institutions offering tutoring on the school curriculum will be registered as non-profit organisations, and no new licences [sic] will be granted." On this news, the price of Gaotu's ADSs fell 63.3% to close at $3.52 per ADS on July 23, 2021, damaging investors.

Then, on November 6, 2021, the Financial Times published an article entitled "How China's tech bosses cashed out at the right time-Sales of US-listed shares came ahead of significant moves in price." The article detailed the unreported trade of a shell company holding shares of executives at Gaotu. The sale occurred in March 2021, ahead of the ban on for-profit tutoring, when the shares were worth as much as $119m, compared to their $4m value at the time of reporting.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Gaotu Techedu Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:GOTU

Release Summary
Gaotu Techedu Inc. (GOTU) Failed to Disclose the Impact of China's Ban on For-Profit Tutoring on Its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom